FDA Inspection 997610 — Mid-America Transplant Services

Mid-America Transplant Services — FEI 3001238381

The FDA completed an inspection of Mid-America Transplant Services on January 4, 2017 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 4, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Saint Louis, MO (United States)